Salvatore J. Enna

Salvatore J. Enna's AcademicInfluence.com Rankings

Salvatore J. Enna

Medical

#1524

World Rank

#1871

Historical Rank

Neurochemistry

World Rank

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Salvatore J. Enna Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Salvatore J. Enna's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Neurochemical aspects of the ontogenesis of gabanergic neurons in the rat brain (1976) (697)
Properties of γ-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions (1975) (596)
Influences of Ions, Enzymes, and Detergents on γ-Aminobutyric Acid-Receptor Binding in Synaptic Membranes of Rat Brain (1977) (392)
Neurotransmitter Receptor Binding (1984) (383)
Muscimol binding in rat brain: Association with synaptic GABA receptors (1978) (364)
Pre- and postsynaptic neurochemical alterations in Alzheimer's disease (1978) (323)
Neurotransmitter receptors in frontal cortex of schizophrenics. (1979) (256)
Age-related alterations in the rodent brain cholinergic system and behavior (1980) (243)
Differential effects of antidepressant treatment on brain monoaminergic receptors. (1980) (215)
Dopamine receptor binding in the corpus striatum of mammalian brain. (1975) (199)
Current protocols in pharmacology (1998) (189)
Huntington's chorea. Changes in neurotransmitter receptors in the brain. (1976) (187)
Effect of aging on neurotransmitter receptor binding in rat and human brain. (1979) (169)
Stereospecificity and structure-activity requirements of GABA receptor binding in rat brain (1977) (157)
A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen (1985) (153)
Methods in Neurotransmitter Receptor Analysis (1990) (140)
Biochemical and electrophysiological characteristics of mammalian GABA receptors. (1983) (139)
Benzodiasepine and neurotransmitter receptor binding in rat brain after chronic administration of diazepam or phenobarbital (1978) (136)
Alterations of brain neurotransmitter receptor binding in Huntington's chorea (1976) (135)
Undernutrition and the development of brain neurotransmitter systems. (1984) (135)
Absorption of drugs from the rat lung. (1972) (134)
Absorption of saccharides and urea from the rat lung. (1972) (133)
Biochemical pharmacology of GABAergic agonists. (1979) (125)
Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders. (1977) (124)
Gamma-aminobutyric acid (GABA) receptor binding in mammalian retina (1976) (121)
Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency (1976) (119)
beta-Adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system. (1980) (118)
Neuroleptics : neurochemical, behavioral, and clinical perspectives (1983) (114)
Characterization of the relationship between gamma-aminobutyric acid B agonists and transmitter-coupled cyclic nucleotide-generating systems in rat brain. (1985) (113)
The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding (1982) (112)
Securinine alkaloids: A new class of GABA receptor antagonist (1985) (108)
Regional distribution of postsynaptic receptor binding for gamma-aminobutyric acid (GABA) in monkey brain (1975) (105)
Receptors for neurotransmitters and peptide hormones. (1980) (98)
Antidepressants : neurochemical, behavioral, and clinical perspectives (1981) (97)
Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding. (1981) (96)
Neurobiology and pharmacology of Huntington's disease. (1977) (95)
Measurement of gamma-aminobutyric acid (GABA) in blood. (1978) (91)
Biochemical identification of pharmacologically and functionally distinct GABA receptors in rat brain (1981) (90)
GABAB receptors and norepinephrine-stimulated cAMP production in rat brain cortex (1984) (88)
Evidence for pharmacologically distinct GABAB receptors associated with cAMP production in rat brain (1996) (88)
Characteristics of muscimol accumulation in mouse brain after systemic administration (1979) (86)
Comparison of the antinociceptive effect of gamma-aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement. (1982) (86)
GABA receptor pharmacology. Functional considerations. (1981) (78)
The GABAB receptor as a target for antidepressant drug action (2011) (75)
Development of muscarinic cholinergic and GABA receptor binding in chick embryo brain (1976) (72)
Norepinephrine and gamma‐aminobutyric acid in amyotrophic lateral sclerosis (1980) (70)
Properties of gamma-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions. (1975) (70)
Influence of adrenocorticotropin hormone and yohimbine on antidepressant-induced declines in rat brain neurotransmitter receptor binding and function. (1982) (70)
Nociceptive regulation of GABAB receptor gene expression in rat spinal cord (1999) (69)
The influence of ACTH and corticosterone on [3H]GABA receptor binding in rat brain (1982) (69)
Brain neurotransmitters and receptors in aging and age-related disorders (1981) (69)
Receptor regulation: evidence for a relationship between phospholipid metabolism and neurotransmitter receptor-mediated cAMP formation in brain (1987) (67)
Evidence for pharmacologically distinct subsets of GABAB receptors (1988) (63)
Effect of imipramine and adrenocorticotropin administration on the rat brain norepinephrine-coupled cyclic nucleotide generating system: alterations in alpha and beta adrenergic components. (1985) (62)
GABA Pharmacology: The Search for Analgesics (2014) (62)
Excitatory amino acid receptors: a gallery of new targets for pharmacological intervention. (1994) (61)
Antinociceptive effects of bradykinin antagonists. (1987) (61)
Development of rat brain uptake and calcium-dependent release of GABA (1978) (59)
Activation of alpha-2 adrenergic receptors augments neurotransmitter-stimulated cyclic AMP accumulation in rat brain cerebral cortical slices. (1986) (59)
Biochemical identification of multiple GABAB binding sites: association with noradrenergic terminals in rat forebrain (1983) (54)
Pharmacological Management of Neurological and Psychiatric Disorders (1998) (50)
Phenol red absorption from the rat lung: Evidence of carrier transport (1973) (49)
Brain mechanisms associated with therapeutic actions of benzodiazepines: focus on neurotransmitters. (1977) (48)
Drugs and the brain (1992) (47)
Adrenergic receptors in rat spinal cord (1982) (46)
The parafasciculus thalami as a site for mediating the antinociceptive response to GABAergic drugs (1986) (44)
Effect of γ-vinyl GABA on bicuculline-induced seizures (1981) (43)
A procedure for measuring α2-adrenergic receptor-mediated inhibition of cyclic AMP accumulation in rat brain slices (1986) (41)
Effect of antidepressants on GABAB receptor function and subunit expression in rat hippocampus (2004) (41)
Differential Regulation of GABAB Receptor Subunit Expression and Function (2003) (40)
Phylogenetic distribution of bicuculline-sensitiveγ-amino-butyric acid (GABA) receptor binding (1980) (40)
Glucocorticoid administration increases receptor-mediated and forskolin-stimulated cyclic AMP accumulation in rat brain cerebral cortical slices (1989) (39)
Properties of 3H-cimetidine binding in rat brain membrane fractions. (1980) (39)
THIP analgesia: cross tolerance with morphine. (1983) (38)
Low Density Lipoprotein Receptor Related Protein (2008) (38)
Defining the role of pharmacology in the emerging world of translational research. (2009) (36)
GABAB receptor function and subunit expression in the rat spinal cord as indicators of stress and the antinociceptive response to antidepressants (2006) (35)
Guidelines for manuscript submission in the peer-reviewed pharmacological literature. (2015) (35)
Phorbol esters down-regulate protein kinase C in rat brain cerebral cortical slices. (1986) (33)
Amitriptyline prevents thermal hyperalgesia and modifications in rat spinal cord GABA(B) receptor expression and function in an animal model of neuropathic pain. (2005) (32)
Overview of pharmacological approaches to therapy for Tourette syndrome. (1982) (32)
GABA uptake inhibitors produce a greater antinociceptive response in the mouse tail-immersion assay than other types of GABAergic drugs. (1985) (31)
In vitro modulation of CNS β-receptor number by antidepressants and β-agonists (1979) (30)
Synergistic interaction between α- and β -adrenergic receptors in rat brain slices: Possible site for antidepressant drug action (1985) (29)
The GABA agonist THIP, attenuates antinociception in the mouse by modifying central cholinergic transmission (1987) (29)
Constitutive expression of functional GABAB receptors in mIL‐tsA58 cells requires both GABAB(1) and GABAB(2) genes (2001) (28)
Proteasome Regulator Marizomib (NPI-0052) Exhibits Prolonged Inhibition, Attenuated Efflux, and Greater Cytotoxicity than Its Reversible Analogs (2011) (28)
The effect of mouse spinal cord transection on the antinociceptive response to the γ-aminobutyric acid agonists THIP (4, 5, 6, 7-tetrahydroisoxazolo [5, 4-c]pyridine-3-ol) and baclofen (1985) (26)
Interaction between GABA agonists and the cholinergic muscarinic system in rat corpus striatum. (1980) (26)
Relationship between the antinociceptive response to desipramine and changes in GABAB receptor function and subunit expression in the dorsal horn of the rat spinal cord. (2004) (25)
Six decades of GABA. (2004) (23)
Neurochemical and behavioral correlates of antidepressant drug action. (1982) (22)
Cerebrospinal Fluid γ-Aminobutyric Acid Correlation with Cerebrospinal Fluid and Blood Constituents and Alterations in Neurological Disorders (1980) (21)
Nociceptive regulation of GABA(B) receptor gene expression in rat spinal cord. (1999) (20)
Multiple bradykinin receptors: results of studies using a novel class of receptor antagonists. (1988) (20)
Problems in GABA research (1983) (20)
Selective interaction of tricyclic antidepressants with a subclass of rat brain cholinergic muscarinic receptors. (1987) (19)
(+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion. (1991) (19)
GABAB receptor agonists and antagonists: pharmacological properties and therapeutic possibilities. (1997) (19)
In vivo or in vitro exposure to imipramine reduces α 2-adrenoceptor-mediated inhibition of cyclic AMP production in rat brain cerebral cortical slices (1987) (18)
The role of central glycine receptors in the pharmacologic actions of benzodiazepines. (1975) (18)
CGP 56999A, a GABAB receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway (2006) (18)
Influences ions, enzymes, and detergents on gamma-aminobutyric acid-receptor binding in synaptic membranes of rat brain. (1977) (18)
Modulation of receptor-mediated cyclic AMP production in brain (1987) (18)
Muscimol: Brain penetration and anticonvulsant potency following GABA-T inhibition (1980) (17)
Comparison of 3H-Muscimol and 3H-GABA Receptor Binding in Rat Brain (1978) (17)
Sites of origin and rostrocaudal concentration gradients of GABA in cerebrospinal fluid (1980) (17)
Neurochemical effects of kojic amine, a gabamimetic, and its interaction with benzylamine oxidase (1981) (16)
Effect of antidepressants on GABA(B) receptor function and subunit expression in rat hippocampus. (2004) (16)
GABAB receptors and transmitter-stimulated cAMP accumulation in rat brain (1984) (16)
Specific inhibition by -methyltyrosine of amphetamine-induced amine release from brain. (1973) (15)
Subcellular distribution of reserpine in blood platelets: evidence for multiple pools. (1974) (14)
Autoradiographic localization of [3H]reserpine binding sites in rat brain. (1977) (14)
Radioligand Binding Assays (1984) (14)
Phosphorus analogues of gamma-aminobutyric acid, a new class of anticonvulsants. (1984) (14)
Antidepressant administration has a differential effect on rat brain alpha 2-adrenoceptor sensitivity to agonists and antagonists. (1986) (14)
The influence of electroshock on adrenoceptor function in rat brain cerebral cortex: selectivity for the alpha-adrenoceptor site. (1988) (14)
Phylogenetic characteristics of muscimol-activated benzodiazepine receptor binding (1980) (13)
GABAB receptor signaling pathways (2001) (13)
Chapter 21: The Receptor: From Concept to Function (1986) (12)
An in vivo procedure for the selective inactivation of rat brain cerebral cortical α-adrenoceptors using N-ethoxycarbonyl-2-ethoxy1,2-dihydroquinoline (EEDQ) (1989) (12)
Regional distribution of persistently bound reserpine in rat brain. (1971) (12)
Stereospecificity and clinical potency of neuroleptics (reply) (1977) (11)
[3H]tetrahydrotrazodone binding. Association with serotonin binding sites. (1983) (11)
Recent advances in alpha1-adrenoceptor pharmacology. (2004) (11)
Effect of gamma-vinyl GABA on bicuculline-induced seizures. (1981) (11)
Effects of stress and tranylcypromine on amphetamine-induced locomotor activity and GABA(B) receptor function in rat brain. (2003) (11)
15-Deoxy-delta-12, 14 PGJ-2 (2008) (11)
Binding and function of serotonin2 receptors following chronic administration of imipramine (1984) (10)
Evidence for cholinergic muscarinic receptors on mediodorsal thalamic projections to the anterior cingulate cortex (1983) (10)
Ontogeny of GABAB receptor subunit expression and function in the rat spinal cord (2003) (9)
Differential regulation of GABA B receptor subunit expression and function. (2003) (9)
A procedure for measuring alpha 2-adrenergic receptor-mediated inhibition of cyclic AMP accumulation in rat brain slices. (1986) (9)
Neurochemical characteristics of rats distinguished as benzodiazepine responders and non-responders in a new conflict test. (1984) (9)
(R)-nipecotic acid ethyl ester: a direct-acting cholinergic agonist that displays greater efficacy at M2 than at M1 muscarinic receptors. (1987) (9)
Comparative effects of benzodiazepines and non-benzodiazepine anxiolytics on biochemical and behavioral tests predictive of anxiolytic activity. (1979) (8)
X Linked Inhibitor of Apoptosis (2008) (8)
Biochemical and behavioral studies following subchronic administration of GABA uptake inhibitors in mice (1991) (8)
An examination of the involvement of phospholipases A2 and C in the alpha-adrenergic and gamma-aminobutyric acid receptor modulation of cyclic AMP accumulation in rat brain slices. (1986) (8)
Role of gamma-aminobutyric acid in anxiety. (1984) (8)
Glucagon-like Peptide-1 (7-36) Amide (2008) (8)
Adrenergic receptors in rat spinal cord (1982) (7)
Interferon Inducible Protein 10 (2008) (7)
Developmental regulation of GABAB receptor function in rat spinal cord (2001) (7)
Glycine, GABA and Benzodiazepine Receptors (1980) (7)
GABAB receptor pharmacology - a tribute to Norman Bowery. Preface. (2010) (7)
In vitro modulation of CNS beta-receptor number by antidepressants and beta-agonists. (1979) (6)
Ontogeny of GABA(B) receptor subunit expression and function in the rat spinal cord. (2003) (6)
Augmentation of neurotransmitter receptor-stimulated cyclic AMP accumulation in rat brain: differentiation between the effects of baclofen and phorbol esters (1988) (6)
Binding of [ 3 H ]desglycinyl remacemide to rat brain membranes: association with the benzomorphan attachment site of the N-methyl-d-aspartic acid receptor channel (1999) (6)
SupersensitiveΒ-adrenergic receptors are down-regulated in rat brain by mianserin administration (2005) (6)
Glucagon-like Peptide-1 (7-37) (2008) (6)
Phylogenetic distribution of bicuculline-sensitive gamma-amino-butyric acid (GABA) receptor binding. (1980) (6)
Soybean Trypsin Inhibitor (2008) (6)
Drug-induced alterations in neurotransmitter receptor binding and function. (1980) (5)
The influence of hormones on drug-induced modifications in neurotransmitter receptor binding. (1982) (5)
Pharmacological characterization of sigma binding sites in guinea pig brain membranes. (1991) (5)
Characteristics of storage and release of metaraminol in the rat heart. (1972) (5)
DIFFERENCES IN AMINE STORAGE IN RAT HEART AND BRAIN (1974) (5)
The GABA Receptor Assay: Focus on Human Studies (1978) (5)
Chronology of neurochemical alterations induced by GABA agonist administration. (1981) (5)
On the nature of the adrenergic neuron extragranular amine binding site (2005) (5)
Cellular and Biochemical Responses to GABAB Receptor Activation (1997) (5)
Prospects for neurodegenerative and psychiatric disorder drug discovery (2011) (4)
Brain penetrability and behavioral effects of muscimol (1979) (4)
Synergistic interaction between alpha- and beta-adrenergic receptors in rat brain slices: possible site for antidepressant drug action. (1985) (4)
Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Peptide Receptors (2007) (4)
Huntington's Disease Biogenic Amines in Cerebrospinal Fluid (1980) (4)
Chapter 5 Amino Acid Neurotransmitter Candidates (1979) (4)
Receptors and the common cold. (1989) (4)
On-Line Submission and Review (2002) (4)
Principles of Receptor Binding Assays: The Gaba Receptor (1984) (3)
Pharmacology of G protein coupled receptors (2011) (3)
Receptor Binding Assays and Drug Discovery. (2018) (3)
The effect of muscimol on hippocampal pyramidal cells. (1979) (3)
β-adrenergic receptor regulation and antidepressants: The influence of adrenocorticotropin (2005) (3)
Glut1 Glucose Transporter 1 (2007) (3)
A legacy of discovery: From monoamines to GABA (2011) (3)
Effects of dopaminergic drugs on cerebrospinal fluid GABA concentration in Parkinson's disease (1980) (2)
Developmental regulation of GABA(B) receptor function in rat spinal cord. (2001) (2)
Receptor modulation in brain slices (1986) (2)
Perspectives of current research activities. Preface. (2009) (2)
Regional variation and characteristics of GABA-receptors in the mammalian CNS. (1979) (2)
Short Protocols in Pharmacology and Drug Discovery: A Compendium of Methods from Current Protocols in Pharmacology (2007) (2)
Reduced Nicotinamide Adenine Dinucleotide Phosphate (2008) (2)
Insulin-Like Growth Factor-2 (2008) (2)
gamma-Aminobutyric acidB receptor activation modifies agonist binding to beta-adrenergic receptors in rat brain cerebral cortex. (1989) (2)
2,4-Dinitrophenol (2008) (2)
Sphingosine Kinase 1 (2007) (2)
Reduced Nicotinamide Adenine Dinucleotide (2008) (2)
Amino acids, peptides and benzodiazepines (1980) (2)
The decreased number of new drug approvals (NDAs) has been a topic of considerable debate over the past decade. Preface. (2009) (2)
5 7 Dihydroxytryptamine (2007) (1)
New advances in molecular pharmacology of Ca2' channels (1989) (1)
Early undernutrition and [3H]gamma-aminobutyric acid binding in rat brain. (1984) (1)
Characteristics of GABA receptor binding in rat brain (1975) (1)
Alpha 2 Antiplasmin (2008) (1)
PHOSPHORUS ANALOGS OF Γ-AMINOBUTYRIC ACID, A NEW CLASS OF ANTICONVULSANTS (1984) (1)
Monographs in neural sciences Vol. 10, neuroreceptors in health and disease: edited by J. Marwaha and W. J. Anderson, S. Krager, 1984. SFr. 149 (US$ 89.25) (vi + 255 pages) ISBN 3 8055 3715 8 (1985) (1)
Brain serotonin receptors and neuropsychiatric disorders. (1981) (1)
Glycoprotein Hormone Receptors (2007) (1)
Drug Stories--of Origins and Uses (2000) (1)
Biochemical Approaches for Evaluating Drug—Receptor Interactions (1987) (1)
Coagulation Factor IX-X-Binding Protein (2008) (1)
Alpha-Conotoxin MII (2008) (1)
5-Isothiocyanato-2-Benzofuranyl-2-Imidazoline (2008) (1)
Radioreceptor Assays for Neurotransmitters and Drugs (1982) (1)
Sites of origin and rostrocaudal concentration gradients of cerebrospinal fluid gaba in man (1979) (1)
Fifty years of Biochemical Pharmacology: the discipline and the journal. (2008) (1)
GABA Receptors: clinical implications (1984) (1)
BIOCHEMICAL ASSAYS FOR NEUROTRANSMITTER RECEPTORS IN THE BRAIN: FOCUS ON γ-AMINOBUTYRIC ACID (1976) (1)
Halogen and non-halogen leaving groups enhance the potency of β-lactone proteasome inhibitors: further investigation into the role of the halogen of NPI-0052 (salinosporamide A) (2008) (1)
Cytokine Response Modifier A (2008) (1)
Chapter 12 Radioreceptor Assays (1982) (1)
Corn Trypsin Inhibitor (2008) (1)
Enhancement of pulmonary drug absorption in the rat by bromphenol blue and related dyes. (1977) (1)
A tribute to Norman G Bowery (2018) (1)
Cyclo19,31[D-Cys19]-uPA19-31 (2008) (0)
MC-5 Melanocortin Receptor (2007) (0)
Coagulation Factor XIa as an Agent (2008) (0)
Guanidinoethyl-Mercaptosuccinic Acid (2008) (0)
Publisher's note of concern (2022) (0)
Sex hormones and the neurochemical response to antidepressant drugs (1981) (0)
Williams Tribute Special Issue preface (2018) (0)
OCTN Organic Cation-Sodium Transporters (2007) (0)
Met-Chemokine beta7 (2008) (0)
Ro 41-1049 (2008) (0)
Dodecyl Octaoxyethylene Ether (2008) (0)
15-Deoxy-15, 15-Ethylenedioxy-16-Phenoxy-Omega-Tetranor PGF-2alpha (2008) (0)
Insulin-Like Growth Factor-1 (2007) (0)
1,1-Dimethyl-4-Acetylpiperazinium Iodide (2008) (0)
Potato Carboxypeptidase Inhibitor (2008) (0)
Contemporary aspects of biomedical research : drug discovery (2009) (0)
CAMKII aa281-302ALA286 (2008) (0)
Preface: A tribute to professor Hanns Möhler. (2015) (0)
Nipecotic acid ethyl ester: a cholinergic agonist that may differentiate muscarinic receptor subtypes (1986) (0)
N-Boc-AEVD-CHO (2008) (0)
nPrNH-(2S,3S)tEps-lle-OH (2008) (0)
Acute respiratory disease. (1969) (0)
9-(Cyclopentenyl)-Adenine (2008) (0)
Editor's Note. (2022) (0)
pGlu-His-Pro-Gly-NH2 (2008) (0)
NK-3 Tachykinin Receptor (2007) (0)
MCH-1 Melanin-Concentrating Hormone Receptor (2007) (0)
NNC 92-1687 2-(Benzimidazol-2-ylthio)- 1-(3,4-Dihydroxyphenyl-1-Ethan one (2008) (0)
2-Me-5HT (2008) (0)
Growth Hormone (GH) Receptor (2007) (0)
MCH-2 Melanin-Concentrating Hormone Receptor (2007) (0)
Potassium Sparing Diuretics (2007) (0)
1-Deoxo PGF-2alpha (2008) (0)
CME Monograph Tests (1984) (0)
Dansyl-Glu-Gly-Arg-Chloromethylketone (2008) (0)
Coagulation Factor X as an Agent (2008) (0)
4-Benzyloxy-3,5-Dimethoxy-N-[(1-Dimethylaminocyclopentyl)Methyl]Benzamide (2008) (0)
Neural regulatory mechanisms during aging. R.C. Adelman, J. Roberts, G.T. Baker, S.I. Baskin, and V.J. Cristofalo, Editors, New York: Alan R. Liss, 1980. 246 pp, $25.00 (1982) (0)
6-Tridecylresorcyclic Acid (2008) (0)
Regulation of Neurotransmitter Responses in the Central Nervous System. (1987) (0)
Acknowledgment to reviewers (1979) (0)
Amyloid Precursor Protein (2008) (0)
Phorbol 13 Acetate 12 Myristate (2008) (0)
BB1 Bombesin Receptor (2007) (0)
An International Initiative in Biomedical Research Training (2008) (0)
Cardiovascular pharmacology : heart and circulation (2010) (0)
CAMKII aa290-309 (2008) (0)
BB2 Bombesin Receptor (2007) (0)
2061 – REGIONAL VARIATIONS IN GABA RECEPTOR AFFINITY IN HUMAN BRAIN (1978) (0)
Arg10 NH 2 (2008) (0)
CCR6 Chemokine Receptor (2007) (0)
2013 Daniel H. Efron Research Award (2012) (0)
16-Phenoxy-Omega-Tetranor PGF-2alpha (2008) (0)
Expression of concern (2022) (0)
Z-VAD-FMK (2008) (0)
Preface: a tribute to professor Hanns Möhler. (2015) (0)
Amino-oxypentane (AOP)-RANTES (2008) (0)
SDZ 64-412 (2008) (0)
O-Methyl-O-(p-Nitrophenyl) n-Undecylphosphonate (2008) (0)
Phytosphingosine-1-Phosphate (2007) (0)
Drug-induced lung disease. (1969) (0)
11-Deoxy PGE-1 (2008) (0)
Filgrastim (G-CSF) (2007) (0)
19R-19-Hydroxy PGE-2 (2008) (0)
Des-AA1,5[125ITyr2, D-Trp8, IAmp9]-SRIF (2008) (0)
15-Oxo PGF-2alpha (2008) (0)
CCK Cholecystokinin Receptors (2007) (0)
VPAC-1 Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Peptide Receptor (2007) (0)
OCT Organic Cation Transporters (2007) (0)
D-Helical Peptide 294 (2008) (0)
CP-481,715 (2008) (0)
(6bS,7R,8S)-7-methoxy-4,8,9-trihydroxy-1,6b,7,8-tetrahydro-2H-benzo(j)fluoranthen-3-one(1) (2008) (0)
Alpha-Conotoxin AuIB (2008) (0)
Modification of cerebro spinal fluid gamma amino butyric acid and mono amine content by gamma amino butyric acid ergic drugs (1979) (0)
2-(2-Benzofuranyl)-2-Imidazoline (2008) (0)
pGlu-3CH3-His-Pro-NH2 (2008) (0)
Lipophilic Alpha-Keto Amide (2008) (0)
2-(Benzothiazolethio) Acetamide Derivative-1a (2008) (0)
MC-1 Melanocortin Receptor (2007) (0)
Small Monomeric GTPases (2007) (0)
des-Gln14-Ghrelin (2008) (0)
Alpha 2 Macroglobulin (2008) (0)
Delta-12 PGJ-2 (2008) (0)
Perspectives in Pharmacology Challenges in the Search for Drugs to Treat Central Nervous System Disorders (2009) (0)
(R,S)-MCPG (2008) (0)
Sphingosine Kinase 2 (2007) (0)
Protein C Inhibitor (2008) (0)
15R PGF-2alpha (2007) (0)
CCK-1 Cholecystokinin Receptor (2007) (0)
ONO-AE-248 (2008) (0)
CLIK-166Ethyl-3-(6-Methyl-5-(Phenylmethoxy)-4-vinyl-3-pyridyl)propionate (2008) (0)
Azepanone 20, SB-357114 (2008) (0)
Note to readers. Re: "AHR signaling in prostate growth, morphogenesis, and disease". (2009) (0)
ONO-AE-329 (2008) (0)
Neuronal (alpha Bungarotoxin-Insensitive) Nicotinic Acetylcholine Receptor (2007) (0)
Neurotransmitter and Hormone Receptors (1981) (0)
Azepanone SB-468430 (2008) (0)
Lysergic Acid Diethylamide (2008) (0)
CCK-2 Cholecystokinin Receptor (2007) (0)
Biochemical identification of the gamma-aminobutyric acid (GABA) receptor in mammalian brain [proceedings]. (1977) (0)
RNA Aptamer 9.3 (2008) (0)
Des-His 1-[Glu9]Glucagon Amide (2008) (0)
Dihydro Beta Erythroidine (2007) (0)
MC-4 Melanocortin Receptor (2007) (0)
Dodecyldithio-5-(2-Nitrobenzoic Acid) (2008) (0)
Contents, Vol. 17, Supplement 1, 1984 (1984) (0)
Morpholine-4-Carboxylic Acid [1S-(2-Benzyloxy-1R-Cyano-Ethylcarbamoyl)-3-Methylbutyl]amide (2008) (0)
Z-Phe-Cys(SBzl)-CH 2 O-CO-2,6-(CF3)2-Ph (2007) (0)
15R-17-Phenyl-Omega-Trinor PGF-2alpha (2008) (0)
6-Chloro-2-(2-Hydroxybiphenyl-3-yl)-1H-Indole-5-Carboxamidine (2008) (0)
Reply (0)
Echis Carinatus Leucogaster Venom Coagulation Factor IX-X-Binding Protein (2008) (0)
Leu-CH 3 (2008) (0)
Beta-CH-TRH (2008) (0)
Preface (2012) (0)
PARgamma Proteinase-Activated Receptor (2007) (0)
Gonadotropin Releasing Hormone (2007) (0)
Effects of ovarian steroids on receptor levels for neurotransmitters in the CNS (1980) (0)
Ro 32-0432 (2008) (0)
BB3 Bombesin Receptor (2007) (0)
Neurochemical alterations following chronic inhibition of GABA transaminase (1979) (0)
Diamond Jubilee Special Issue: Celebrating 60 years of Excellence. (2018) (0)
TYR 0 sauvagine (2008) (0)
Plant Serine Protease Inhibitor (2008) (0)
4 Methylglutamic Acid (2008) (0)
Note to Readers. (2009) (0)
4,6-O-Ethylidene Glucose (2008) (0)
Difluoro Ketone Peptidomimetic (2008) (0)
NT(8-13) (2008) (0)
Gaba receptor binding assays (1979) (0)
8-Methoxymethyl-1-Methyl-1-3-(2-Methylpropyl)Xanthine (2008) (0)
1-Deoxo-1-O-Methyl PGF-2alpha (2008) (0)
1503 – PROPERTIES AND REGIONAL DISTRIBUTION OF THE SYNAPTIC GABA RECEPTOR IN MAMMALIAN BRAIN (1977) (0)
Note to Readers (2002) (0)
pGlu-Glu-Pro-NH2 (2007) (0)
16, 16-Dimethyl PGE-2 (2008) (0)
Comprar Short Protocols in Pharmacology and Drug Discovery | S. J. Enna | 9780470095263 | Wiley (2007) (0)
Sphingosine-1-Phosphate Lyase (2007) (0)
Modification of cerebrospinal fluid gaba and monoamine content by gabaergic drugs (1979) (0)
L-779,976 (2008) (0)
Radioreceptor assays--discussion. (1979) (0)
Complement Component C1s Inhibitor (2008) (0)
2-[3 -(Trifluoromethyl) phenyl] histamine (2008) (0)
Phylogenetic and pharmacological characteristics of muscimol activated benzodiazepine receptor binding (1979) (0)
Neurochemical alterations in aging (1981) (0)
MIP Major Intrinsic Proteins (2007) (0)
L-Homocysteinesulphinic Acid (2008) (0)
Ac-WEHD-CHO (2008) (0)
Pyridine-3-Aldehyde (2008) (0)
Phage-Derived Hexapeptide (2008) (0)
Voltage-Sensitive Potassium Channels (2007) (0)
Acute Tubular Necrosis (2007) (0)
Muscle Nicotinic Acetylcholine Receptor (2007) (0)
19R-19-Hydroxy PGF-2alpha (2008) (0)
MC-2 Melanocortin Receptor (2007) (0)
Z-Leu-Leu-Tyr-CHN 2 (2008) (0)
VPAC-2 Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Peptide Receptor (2007) (0)

This paper list is powered by the following services:

Salvatore J. Enna's Academic­Influence.com Rankings

Why Is Salvatore J. Enna Influential?

Salvatore J. Enna's Published Works

Published Works

Salvatore J. Enna's AcademicInfluence.com Rankings